Barclays’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $32K | Hold |
30,197
| – | – | ﹤0.01% | 4016 |
|
2025
Q1 | $33K | Hold |
30,197
| – | – | ﹤0.01% | 3975 |
|
2024
Q4 | $45K | Sell |
30,197
-51
| -0.2% | -$76 | ﹤0.01% | 3973 |
|
2024
Q3 | $45K | Sell |
30,248
-434,704
| -93% | -$647K | ﹤0.01% | 3936 |
|
2024
Q2 | $753K | Sell |
464,952
-28,598
| -6% | -$46.3K | ﹤0.01% | 2278 |
|
2024
Q1 | $839K | Sell |
493,550
-23,814
| -5% | -$40.5K | ﹤0.01% | 2523 |
|
2023
Q4 | $1.6M | Buy |
517,364
+46,352
| +10% | +$144K | ﹤0.01% | 2298 |
|
2023
Q3 | $2.89M | Buy |
471,012
+230,692
| +96% | +$1.42M | ﹤0.01% | 1462 |
|
2023
Q2 | $1.5M | Sell |
240,320
-15,602
| -6% | -$97.6K | ﹤0.01% | 1917 |
|
2023
Q1 | $1.22M | Buy |
255,922
+93,603
| +58% | +$446K | ﹤0.01% | 1991 |
|
2022
Q4 | $1.41M | Sell |
162,319
-31,552
| -16% | -$274K | ﹤0.01% | 1868 |
|
2022
Q3 | $2.31M | Buy |
193,871
+71,120
| +58% | +$847K | ﹤0.01% | 1557 |
|
2022
Q2 | $1.75M | Buy |
122,751
+114,042
| +1,309% | +$1.62M | ﹤0.01% | 1678 |
|
2022
Q1 | $182K | Buy |
+8,709
| New | +$182K | ﹤0.01% | 3370 |
|